메뉴 건너뛰기
Journal of Thoracic Oncology
Volumn 7, Issue 2, 2012, Pages 269-271
Dutch statistics on lung cancer: Sobering experience for a new approach
Author keywords

[No Author keywords available]
Indexed keywords

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA;
EID: 84858302630     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31823ab5fb     Document Type: Editorial
Times cited : (7)
References (8)
  • 1
    • 84858310285 scopus 로고    scopus 로고
    • Progress in standard of care therapy and modest survival benefits in the treatment of NSCLC patients in the Netherlands in the past 20 years
    • van der Drift MA, Karim-Kos HE, Siesling S, et al. Progress in standard of care therapy and modest survival benefits in the treatment of NSCLC patients in the Netherlands in the past 20 years. J Thorac Oncol. 2012;7:291-298.
    • (2012) J Thorac Oncol , vol.7 , pp. 291-298
    • Van Der Drift, M.A.1    Karim-Kos, H.E.2    Siesling, S.3
  • 2
    • 25644461068 scopus 로고    scopus 로고
    • International lung cancer trends by histologic type: Male:female differences diminishing and adenocarcinoma rates rising
    • DOI 10.1002/ijc.21183
    • Devessa SS, Bray F, Vizcaino AP, et al. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005;117:294-299. (Pubitemid 41379403)
    • (2005) International Journal of Cancer , vol.117 , Issue.2 , pp. 294-299
    • Devesa, S.S.1    Bray, F.2    Vizcaino, A.P.3    Parkin, D.M.4
  • 3
    • 85031183784 scopus 로고    scopus 로고
    • Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia
    • Cancer in Slovenia 1989-2008. Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia, 1992-2011.
    • Cancer in Slovenia 1989-2008 , pp. 1992-2011
  • 4
    • 66049091608 scopus 로고    scopus 로고
    • Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials
    • Vardy J, Dadasovich R, Beale P, et al. Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials. BMC Cancer 2009;9:130.
    • (2009) BMC Cancer , vol.9 , pp. 130
    • Vardy, J.1    Dadasovich, R.2    Beale, P.3
  • 5
    • 77954425611 scopus 로고    scopus 로고
    • Stereotactic radiotherapy for pulmonary oligometastases: A systematic review
    • Siva S, MacManus M, Ball D. Stereotactic radiotherapy for pulmonary oligometastases: a systematic review. J Thorac Oncol 2010;5:1091-1099.
    • (2010) J Thorac Oncol , vol.5 , pp. 1091-1099
    • Siva, S.1    MacManus, M.2    Ball, D.3
  • 6
    • 79959348438 scopus 로고    scopus 로고
    • Intermittent chemotherapy and erlotinib for nonsmokers or light smokers with advanced adenocarcinoma of the lung: A phase II clinical trial
    • Zwitter M, Rajer M, Kovac V, et al. Intermittent chemotherapy and erlotinib for nonsmokers or light smokers with advanced adenocarcinoma of the lung: a phase II clinical trial. J Biomed Biotechnol 2011; 2011:185646.
    • (2011) J Biomed Biotechnol , vol.2011 , pp. 185646
    • Zwitter, M.1    Rajer, M.2    Kovac, V.3
  • 8
    • 0032585233 scopus 로고    scopus 로고
    • Trials: The next 50 years. Large scale randomised evidence of moderate benefits
    • Peto R, Baigent C. Trials: the next 50 years. Large scale randomised evidence of moderate benefits. Br Med J 1998;317:1170-1171.
    • (1998) Br Med J , vol.317 , pp. 1170-1171
    • Peto, R.1    Baigent, C.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.